Pharmacological approaches and strategies for therapeutic modulation of fibrinogen.
Handley
D A
DA
Sepracor Inc., Marlborough, MA 01752, USA.
Hughes
T E
TE
D000818:Animals; D015195:Drug Design; D005340:Fibrinogen / Q000187:drug effects / Q000502:physiology; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006801:Humans
D005343:Fibrinolytic Agents; D005340:Fibrinogen